Literature DB >> 26037144

Secretin receptor involvement in prion-infected cells and animals.

Tomohiro Kimura1, Keiko Nishizawa1, Ayumi Oguma1, Yuki Nishimura1, Yuji Sakasegawa1, Kenta Teruya1, Ichiko Nishijima2, Katsumi Doh-ura3.   

Abstract

The cellular mechanisms behind prion biosynthesis and metabolism remain unclear. Here we show that secretin signaling via the secretin receptor regulates abnormal prion protein formation in prion-infected cells. Animal studies demonstrate that secretin receptor deficiency slightly, but significantly, prolongs incubation time in female but not male mice. This gender-specificity is consistent with our finding that prion-infected cells are derived from females. Therefore, our results provide initial insights into the reasons why age of disease onset in certain prion diseases is reported to occur slightly earlier in females than males.
Copyright © 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Gender effect; Incubation time; Knockout mouse; N2a cells; Prion; Secretin receptor

Mesh:

Substances:

Year:  2015        PMID: 26037144     DOI: 10.1016/j.febslet.2015.05.039

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  2 in total

1.  A Single Subcutaneous Injection of Cellulose Ethers Administered Long before Infection Confers Sustained Protection against Prion Diseases in Rodents.

Authors:  Kenta Teruya; Ayumi Oguma; Keiko Nishizawa; Maki Kawata; Yuji Sakasegawa; Hiroshi Kamitakahara; Katsumi Doh-Ura
Journal:  PLoS Pathog       Date:  2016-12-14       Impact factor: 6.823

2.  Decrease in Skin Prion-Seeding Activity of Prion-Infected Mice Treated with a Compound Against Human and Animal Prions: a First Possible Biomarker for Prion Therapeutics.

Authors:  Mingxuan Ding; Kenta Teruya; Weiguanliu Zhang; Hae Weon Lee; Jue Yuan; Ayumi Oguma; Aaron Foutz; Manuel V Camacho; Marcus Mitchell; Justin J Greenlee; Qingzhong Kong; Katsumi Doh-Ura; Li Cui; Wen-Quan Zou
Journal:  Mol Neurobiol       Date:  2021-05-13       Impact factor: 5.590

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.